Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares

The review is devoted to the clinical efficacy of sodium-glucose cotransporter type 2 (SGLT2) inhibitors. Information on the mechanisms of drug action is given, as well as rationale for their use in the management of patients with diabetes and heart failure (HF) is provided. The results of large-sca...

Full description

Saved in:
Bibliographic Details
Main Authors: N. B. Perepech, I. E. Mikhailova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2021-07-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4534
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689711097937920
author N. B. Perepech
I. E. Mikhailova
author_facet N. B. Perepech
I. E. Mikhailova
author_sort N. B. Perepech
collection DOAJ
description The review is devoted to the clinical efficacy of sodium-glucose cotransporter type 2 (SGLT2) inhibitors. Information on the mechanisms of drug action is given, as well as rationale for their use in the management of patients with diabetes and heart failure (HF) is provided. The results of large-scale randomized clinical trials evaluating the efficacy of SGLT2 inhibitors are discussed. We showed the beneficial effect of SGLT-2 inhibitors on the risk of cardiovascular events in patients with type 2 diabetes. In addition, an evidence of the ability of dapagliflozin and empagliflozin to improve the prognosis of patients with HF with reduced ejection fraction without diabetes are presented. The evidence and mechanisms of the nephroprotective action of SGLT2 inhibitors in patients with diabetes and HF are considered.
format Article
id doaj-art-fe3f026a31e64973b029521f97d0b813
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2021-07-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-fe3f026a31e64973b029521f97d0b8132025-08-20T03:21:31Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202021-07-01262S10.15829/1560-4071-2021-45343292Sodium-glucose cotransporter type 2 inhibitors: successful running after two haresN. B. Perepech0I. E. Mikhailova1Saint Petersburg State UniversitySaint Petersburg State UniversityThe review is devoted to the clinical efficacy of sodium-glucose cotransporter type 2 (SGLT2) inhibitors. Information on the mechanisms of drug action is given, as well as rationale for their use in the management of patients with diabetes and heart failure (HF) is provided. The results of large-scale randomized clinical trials evaluating the efficacy of SGLT2 inhibitors are discussed. We showed the beneficial effect of SGLT-2 inhibitors on the risk of cardiovascular events in patients with type 2 diabetes. In addition, an evidence of the ability of dapagliflozin and empagliflozin to improve the prognosis of patients with HF with reduced ejection fraction without diabetes are presented. The evidence and mechanisms of the nephroprotective action of SGLT2 inhibitors in patients with diabetes and HF are considered.https://russjcardiol.elpub.ru/jour/article/view/4534keywords: sodium-glucose cotransporter type 2 inhibitorsdiabetesheart failureprognosis
spellingShingle N. B. Perepech
I. E. Mikhailova
Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
Российский кардиологический журнал
keywords: sodium-glucose cotransporter type 2 inhibitors
diabetes
heart failure
prognosis
title Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
title_full Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
title_fullStr Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
title_full_unstemmed Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
title_short Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
title_sort sodium glucose cotransporter type 2 inhibitors successful running after two hares
topic keywords: sodium-glucose cotransporter type 2 inhibitors
diabetes
heart failure
prognosis
url https://russjcardiol.elpub.ru/jour/article/view/4534
work_keys_str_mv AT nbperepech sodiumglucosecotransportertype2inhibitorssuccessfulrunningaftertwohares
AT iemikhailova sodiumglucosecotransportertype2inhibitorssuccessfulrunningaftertwohares